Samsung Medical Center
| Corea del Sud | Turchia | Austria | |
| Terapia con protoni | da $22,000 | da $70,000 | da $80,000 |
| Sistema robotico Da Vinci | da $12,000 | da $9,500 | da $22,000 |
| Resezione gastrica | da $18,500 | da $16,470 | da $22,000 |
| Immunoterapia con Keytruda (Pembrolizumab) | da $5,200 | da $3,300 | da $15,000 |
| Gastroectomia | da $13,850 | da $18,300 | da $25,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Cancro gastrico. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Cancro gastrico e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Cancro gastrico.
Il medico è il capo del Dipartimento di Oncologia Radioterapica e ha una vasta esperienza in oncologia, avendo completato la formazione specialistica presso il Samsung Medical Center e l'Ospedale dell'Università Nazionale di Seoul. Il medico si è laureato presso il College of Medicine dell'Università Nazionale di Seoul e si specializza nel trattamento del cancro allo stomaco, del cancro pancreatobiliare, dei tumori del SNC, dei tumori pediatrici, dei sarcomi e dei tumori ematologici.<\/p>
Il medico è il Direttore del Centro Oncologico Yonsei presso il Sistema Sanitario dell'Università Yonsei a Seul, Corea del Sud. Specializzato nel trattamento del cancro gastrico avanzato, il medico ha una vasta esperienza in chirurgia, oncologia e gastroenterologia.<\/p>
Il medico ha ricoperto posizioni prestigiose come Presidente dell'Associazione Coreana del Cancro Gastrico e dell'Associazione Internazionale del Cancro Gastrico, e Presidente del Consiglio dell'Associazione Coreana del Cancro e della Società Chirurgica Coreana.<\/p>
Riconosciuto come un chirurgo eccezionale nella chirurgia del cancro gastrico, il medico ha ricevuto numerosi riconoscimenti, tra cui il Premio Accademico per il Cancro e il Premio Accademico Yuhan.<\/p>
Il medico è un esperto di cancro al seno leader in Corea del Sud ed è riconosciuto tra i 100 migliori chirurghi al mondo per il cancro gastrico e al seno. Il medico ha introdotto la chirurgia conservativa del seno in Corea del Sud nel 1986 e ha inventato un intervento chirurgico unico per il cancro allo stomaco che minimizza il rischio di malattia da reflusso gastroesofageo. Attualmente, il medico dirige il Centro per il Cancro delle Donne presso il Centro Medico dell'Università Ewha Womans e ha precedentemente ricoperto il ruolo di Presidente dell'Ospedale Universitario Konkuk e Direttore dell'Ospedale del Centro per il Cancro della Corea. Il medico è anche un ricercatore attivo nella diagnosi e gestione del cancro al seno.<\/p>
South Korea dominates stomach cancer treatment with a global-leading 5-year survival rate exceeding 77%. Survival is significantly higher than in the US or UK. Extensive national screening ensures 63% of cases are diagnosed early. Surgeons maintain elite proficiency through massive procedure volumes.
Bookimed Expert Insight: While many countries prioritize chemotherapy first, South Korean centers like Seoul National University Hospital leverage massive surgical data to prefer aggressive early intervention. This high-volume expertise allows clinics like Asan Medical Center to maintain surgical complication rates below 5%, which is significantly lower than the 15% global average.
Patient Consensus: Patients travel to Seoul specifically for procedures like endoscopic submucosal dissection to preserve their stomach and return to a normal diet quickly. Many note that the speed of care is impressive, with treatment starting within two weeks of arrival.
Medical centers in Korea provide comprehensive treatments including endoscopic resection, laparoscopic gastrectomy, and robotic-assisted surgery. Specialized oncology centers also offer advanced non-surgical options like target therapy, immunotherapy with Keytruda, and HIPEC. High surgical volumes contribute to survival rates exceeding 70% for advanced cases.
Bookimed Expert Insight: Samsung Medical Center and Asan Medical Center handle massive patient volumes, with Asan treating over 11,000 outpatients daily. This high frequency allows surgeons like Dr. Sung Hoon Noh at Severance Hospital to refine techniques for complex D2 lymph node dissections. This expertise is a primary reason why Korea maintains a global rank of 4 in our medical destination database.
Patient Consensus: Patients emphasize that Korean centers are much more aggressive with palliative care, such as offering HIPEC or stenting, compared to conservative western approaches. Many note that having an English-speaking coordinator is vital for navigating the large, busy hospital campuses in Seoul.
Samsung Medical Center, Severance Hospital, and Asan Medical Center are the primary Seoul institutions treating international stomach cancer patients. These JCI-accredited facilities offer robotic gastrectomy and advanced immunotherapy. They maintain dedicated international centers to handle the high volume of global oncology cases annually.
Bookimed Expert Insight: While Samsung and Asan lead in total patient volume, Severance Hospital stands out for surgical leadership. Dr. Sung Hoon Noh has served as president of both Korean and international gastric cancer associations. This academic authority makes Severance a strategic choice for complex or advanced-stage gastric cases.
Patient Consensus: Patients note that these hospitals are very large but provide accessible assistance. They emphasize that using a partner for introductions is more effective than self-contacting hospitals.
Patients should plan to stay in South Korea for 4 to 8 weeks for stomach cancer treatment. This period covers essential pre-operative diagnostics, the surgical procedure, and post-operative monitoring. Most surgical cases require at least 10 to 14 days of hospitalization followed by outpatient wound care.
Bookimed Expert Insight: Korea’s leading oncology centers like Samsung Medical Center and SNUH handle massive patient volumes daily. Since these hospitals manage over 10,000 patients every day, surgical schedules are extremely tight. Patients who finalize their biopsy revision and CT scans within the first week avoid long delays. Securing a 2-month medical visa is safer than a standard tourist entry to prevent stressful extension paperwork.
Patient Consensus: Patients note that while the hospitals are large, assistance is always available. Many recommend packing for a 2-month stay as recovery from a total gastrectomy often takes longer than initially expected.
Korean hospitals follow a phased diet starting with ice chips on Day 1. Patients transition to clear liquids by Day 3 and rice porridge by Week 1. This structured protocol focuses on 6 small meals daily. It aim to prevent dumping syndrome and manage reduced stomach capacity.
Bookimed Expert Insight: Korea maintains high cancer treatment statistics at centers like Seoul National University Hospital. Our data shows clinics like Asan Medical Center manage over 65,000 surgeries yearly. This high volume allows Korean teams to refine recovery protocols like ERAS. These protocols prioritize early oral intake to speed up intestinal recovery.
Patient Consensus: Patients note that nurses strictly monitor the 6-meal schedule of watery rice and seaweed soup. Many recommend stocking plain juk packets and protein powders before returning home to ensure easy meal prep.